chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had shingles vaccine got them anyway/Suspected vaccination failure; Got them anyway; got Covid anyway; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis and COVID-19 VACCINE (COVID-19 BOOSTER) for prophylaxis.   On an unknown date, the patient received Shingles vaccine, COVID-19 VACCINE and COVID-19 BOOSTER. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and covid-19. On an unknown date, the outcome of the vaccination failure, shingles and covid-19 were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and covid-19 to be related to Shingles vaccine.     Additional Information: GSK receipt date: 16-Sept-2022 Reporter's comment: The case was received from the patient via (social media) interactive digital media. The patient stated that Covid shots and boosters were useless, got covid anyway. The patient had shingles vaccine and got them anyway. The patient stated no more vaccines for him/her. Additional supportive information: It was unknown if the reporter considered the shingles and covid-19 to be related to Covid-19 vaccine and Covid-19 booster. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. In worst approach, case was kept valid and Covid shots and booster shots single Covid-19 vaccine and Covid-19 booster was coded with blank dose number as it was not clear by the reported narrative.
Client was mistakenly administered Pfizer booster dose when she requested Moderna. Client received Moderna as primary vaccine series. The supervising nurse on site notified the client. Reeducation/remediation was provided to administering nurse.
Information has been received from a nurse practitioner concerning a 24 yr old female health unit coordinator who on 14Sep04 was vaccinated SC in her right deltoid with a 0.5mL dose of varicella virus vaccine live (lot 647763/0191P). Concomitant vaccination that day included a second dose hep B virus vaccine rHBsAg (yeast) (Engerix B) (lot AHBVA058AA), given IM in her deltoid. There was no illness at the time of vaccination. On 26Sep04 the pt experienced headache, muscle ache, rash, swelling at the injection site and redness at the injection site. Unspecified medical attention was sought and the pt was taking acetaminophen (Tylenol) for the headache. It was reported that the pt's adverse events had not yet improved. There was no product quality complaint involved. Follow up information from the nurse practitioner indicated that on 26Sep04 the pt experienced a fever, sore throat, left chest wall pain, and spots over various location including her left arm and back. It was reported that the pt recovered on 04Oct04. There was no adverse event following prior vaccination. No further information is available.
heart palpitations, very bad for about 2 months after getting first shot of the vaccine  went to the doctor and they did EKG and other tests to see  outcome - unknown at this time, however, said it could be likely from having COVID in January and/or getting the vaccine in April
Medical Assistant administered Tdap vaccine to patient instead of ordered pentacel vaccine. Ordering physician made aware, appropriate follow up was reportedly made.
w/in 6hr of vax pt became fussy & irritable;worse on 2nd day on APAP for 4 days;cont fussiness & spitting up for 2min;now on zantac for presumed esophagitis;
This spontaneous case reported by a consumer, describes the occurrence of diarrhea (bad diarrhea after the first shot) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 041J21A) for COVID-19 immunization. No medical history reported. On Jan 26, 2022, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 27, 2022, patient experienced diarrhea (bad diarrhea after the first shot). On Feb 6, 2022, diarrhea (bad diarrhea after the first shot): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication reported. The next day, after the first shot, patient had bad diarrhea. It continued for 10 days. He did not take any medicine and did not inform his doctor. The diarrhea stopped by itself.
"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."
Throbbing pain upon injection, within 10 minutes had increased heart rate, clammy skin, rash at injection site, within 20 minutes had nasal drainage, irritated throat, coughing, feeling faint and dizzy, heart rate kept increasing although was sedentary, started to have trouble breathing.  Took Benadryl and loratadine, observed symptoms to see if epinephrine was needed.
Initial unsolicited report received from a physician on 27-Feb-2018. This case involves a 11-year-old male patient who was vaccinated with a 0.5 ml of single intramuscular dose of ADACEL (Batch number: C5228AA) and MENACTRA (batch number- not reported) (expiry date, dose in series, site was not reported for both the vaccine) on 17-Jan-2018. The patient's medical history were unknown and concomitant medications was not reported. On an unknown date, 15 minutes following vaccination, the patient had developed runny nose and periorbital edema. On an unknown date, following vaccination patient had developed trouble breathing and shortness of breath over next several hours. Lab investigations not reported and corrective treatments were unknown. On an unknown date patient was recovered from all the events. List of documents held by sender: none.
started getting a bad sore throat/it was like I was getting a cold, like strep throat/still had a sore throat/where my Adam's apple is, it feels a little sore; voice dropped about 2 degrees/voice dropped way down/voice felt different; hurt my right shoulder/shoulder is achy; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (started getting a bad sore throat/it was like I was getting a cold, like strep throat/still had a sore throat/where my Adam's apple is, it feels a little sore), DYSPHONIA (voice dropped about 2 degrees/voice dropped way down/voice felt different) and ARTHRALGIA (hurt my right shoulder/shoulder is achy) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (cephamycin), Drug allergy (Flagyl) and Penicillin allergy (Penicillin). Concomitant products included METOPROLOL, SIMVASTATIN, CLOPIDOGREL, ACETYLSALICYLIC ACID (BABY ASPIRIN) and AMLODIPINE for an unknown indication.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced ARTHRALGIA (hurt my right shoulder/shoulder is achy). On 12-Aug-2021, the patient experienced OROPHARYNGEAL PAIN (started getting a bad sore throat/it was like I was getting a cold, like strep throat/still had a sore throat/where my Adam's apple is, it feels a little sore) and DYSPHONIA (voice dropped about 2 degrees/voice dropped way down/voice felt different). At the time of the report, OROPHARYNGEAL PAIN (started getting a bad sore throat/it was like I was getting a cold, like strep throat/still had a sore throat/where my Adam's apple is, it feels a little sore), DYSPHONIA (voice dropped about 2 degrees/voice dropped way down/voice felt different) and ARTHRALGIA (hurt my right shoulder/shoulder is achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 14 years old adolescent patient and unknown gender. On 31-JUL-2014 the patient was vaccinated with a dose of an improperly stored GARDASIL (lot H020901, expiration date 05-JUL-2015) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Patient came in the day after receiving a shingles vaccine and his right wrist and hand was very swollen, was very painful , and he could barely move it.  He asked me if by chance I thought i was related to the vaccine since it was the same arm he received the vaccine in.  There was no pain or redness at the injection site and was just a little painful at the actual site.  After talking to the patient more he said that hand started hurting earlier in the day (before he received the vaccine) but shortly after receiving the vaccine he got these severe symptoms.  He had went camping a week or so prior to and had an issue with his eye getting red and swollen so he didn't know if it was related to that at all.  He also said he put some rub on some ribs that he was grilling and may have used some muscles in his hand that he was not used to when applying the rub and that could be why his hand hurt earlier in the day but he didn't know what caused the symptoms to be so severe.  I followed up with the patient today and he ended up seeing a doctor because it pain and swelling was still bad after the weekend.  He was prescribed prednisone and after the second dose of it things seemed to get better.  The dr is not sure what caused this.
a child was given and EXP vaccine/no AE; a child was given and EXP vaccine of 4th dose at 22 months/no AE; Initial information received on 02-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 22 months old male patient who received an expired dose of vaccine, while he received vaccine HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included INFLUENZA VACCINE (FLU VACCINE VII); PNEUMOCOCCAL VACCINE 13V (PNEUMOCOCCAL 13 VALENT VACCINE); HEPATITIS A VACCINE (HEPATITIS A VACCINE); and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DTAP).  On 02-Oct-2019, the patient received a 4th single 0.5 ml dose of suspect HIB (PRP/T) VACCINE lot UI908AAA, expiry date: 14-Sep-2019 via intramuscular route in the left deltoid.  It was of actual medication error case due to Inappropriate schedule of vaccine administered and expired vaccine used.  It was unknown whether any delayed adverse event was noted or not..  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Patient developed myocarditis resulting in hospitalization at medical center.  He was treated with medications for heart failure, symptoms resolved and he was discharged home with follow up in heart failure clinic.
Dizziness, severe sweating, weakness for about 15 minutes the morning after the injection.
67-year-old female to the ED from home with complaints of worsening shortness of breath, fatigue, chest pain. Diagnosed with COVID-19 5/11. Admitted to inpatient for pneumonia due to COVID 19. She reports muscular chest pain when she coughs. Arrives with hypoxia, decreased breath sounds. Placed on 2LNC. D-dimer, CRP, ferritin elevated. CT chest shows: Diffuse bilateral COVID 19 pneumonia. Start on IV Remdesivir. Trend inflammatory markers. Has had symptoms for 8 days, so out of window for plasma.
Vaccine was stored for freezer temperature for too long.  We have recommended to the patient to get revaccinated.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Oct2021 as dose 2 (booster), single (Lot number: FE3690) at the age of 44 years, in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 08Apr2021 as dose 1, single (Lot number: 041A21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Highly susceptible to nausea and motion sickness" (unspecified if ongoing), notes: Highly susceptible to nausea and motion sickness; "Highly susceptible to nausea and motion sickness" (unspecified if ongoing), notes: Highly susceptible to nausea and motion sickness. Concomitant medication(s) included: PRISTIQ; GABAPENTIN. Past drug history included: Sumatriptan, reaction(s): "Known allergies: Sumatriptan". The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of covid-19, drug ineffective.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a physician refers to multiple patients of unknown demographics. Information regarding the patients' concurrent conditions, medical history and concomitant medications was not provided. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (route of administration, anatomical location, lot number and expiration date were not reported), which were exposed to a "lighted medical refrigerator for weeks" on unspecified dates. No adverse effects were reported. Additional information has been requested.
I received my second Pfizer booster 5/11/22. Within the first week I noticed some skin changes on upper chest. Then shortly thereafter started having hive like rash on about 75 percent of my body. They were very painful and burning itch. After two weeks I saw a dermatologist and started a course of Prednisone of which I had many side effects, and continued to have break thru hives. Dermatologist agreed that this is more likely due to the Covid booster shot. All other causes were ruled out. Now that I am at the end of the weaning off Prednisone I am experiencing an uptake in the hives. I am concerned that this could be a chronic problem. Of course the concern is can I dare have another booster when needed. I had no problem with the first three Covid shots.
Rosacea flared up significantly roughly 3 days are the 2nd Pfizer Covid19 injection.
Sever cough, sore throat, bronchial spasms Had 3 dr visits:  Aug 23, 2021; Aug 26, 2021;  Sept 6, 2021 Had covid test at each appt. all three tests were negative Had chest X-rays at each visit, all were normal Had strep test at 1st visit was negative
Began experiencing strange taste; strange smells; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 02May2021 at 16:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 11Apr2021 at 16:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 08:00, the patient experienced strange smells and taste within 48 hours of vaccine. There was a persistent soapy/floral smell that she experienced each day and certain food items had the same soapy taste. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events strange smells and taste within 48 hours of vaccine, persistent soapy/floral smell, certain food items had the same soapy taste was not recovered at the time of this report.
Pt presented at ER with red raised bumps generalized in the trunk area and a few on the arms and legs.  Pt stated he "popped" some of them this morning.  Rash started about 0900 on 14 May 06.  Pt was sent home until follow-up appointment on 16 May 06.  Pt was instructed to limit contact with others.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Chills lasting until 11:00pm.  Headache. Relieved by ibuprofen.  Completely resolved within 24 hrs.
Sweating (Sweating, Sweating increased). Headache (Headache, Headache). Nausea (Nausea, Nausea). Fever (Fever, Pyrexia). Case description: This 76 year old male started vaccination with Vivotif (typhoid vaccine live oral Ty21a) on 01 APR 2003 and completed routine course on 07 APR 2003. One day after the intake of the last capsule (on 08 APR 2002) the patient experienced headache, sweating, low-grade nausea and fever (100.8-101.8P) for three days. The patient denied other symptoms or evidence of infection. The patient continued to eat and drink adequately. On 13 APR 2003 he had completely recovered and was back to normal status. The patient informally consulted with a collegue (medical missionary) who told him that it is more common to see similar reactions in people receiving oral typhoid vaccine than post injectable.
cough started 12/20/21, positive for covid, went to emergency room 12/22/21, 12/25/21 and had out patient monoclonal ab infusion 12/24/21 2/2/22 patient continues to have cough and hoarseness. referred to pulmonologist
A week after receiving dose 1 of the Moderna COVID19 vaccine, I developed a red, raised, hot, itchy circle of about 1 1/2 inch diameter at my injection site.  I took 2 Benadryl that evening.  The next morning, I took a non-drowsy 24 hours anti-histamine.  The red area continued to grow larger.  Now, 9 days after the injection, the area is the size of a softball and is still hot, red, raised and itchy.  It reminds me of the reactions I would get when I received allergy shots, except those reaction I had within 24 hours of getting my allergy shot instead of being delayed for a week.  On day 9 post-vaccination, I also developed a red, itchy area of about 1 inch diameter on my back.
Pt recvd DT for abrasions on 2SEP91; Returned to clinic w/lt arm swollen/red @ inject site, fever 101.1 & dizziness; Given Atarax;
Chills; sore left arm; sore muscles in whole body; real sore shoulder and rear neck muscles; real sore shoulder and rear neck muscles; Headache; sinus pain; hurt behind my eyes; dizzy when up moving; Nausea after walking; felt real bad for 36 hours; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old male patient received third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8028) via an unspecified route of administration in the left arm on 03Nov2021 at 12:45 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. The medical history reported as old age (79) with few things going on. The patient still works a job. The patient's known allergies were reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 10Feb2021 at 12:15 (at the age of 77-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 04Mar2021 at 12:15 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. On 04Nov2021 at 04:00, the patient experienced chills, sore left arm, sore muscles in whole body, real sore shoulder and rear neck muscles, head ache, sinus pain, hurt behind the eyes, dizzy when up moving, nausea after walking and felt real bad for 36 hours. The patient reported that only thing he didn't have was a temperature and it was 97.2(unknown unit). On the same day, the patient underwent body temperature test and the result was 97.2 (unknown unit). The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, sore left arm, sore muscles in whole body, real sore shoulder and rear neck muscles, head ache, sinus pain, hurt behind the eyes, dizzy when up moving, nausea after walking and was feeling real bad were resolved on an unknown date in Nov2021.
Pt presented to clinic 1 week after immunizations with inability to walk. Hip flexors and quads were not working.